Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis

被引：0
|
作者：
Juanzhi Fang
Stephanie Korrer
Jonathan C. Johnson
Mark A. Cheadle
Roshani Shah
Matias L. Ferraris
Cristina Lopez-Lopez
机构：
[1] Novartis Pharmaceuticals Corporation,
[2] Optum,undefined
[3] Novartis Pharma AG,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Acute; Comorbidity; Erenumab; Migraine; Observational; Preventive; Real world; Retrospective;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2921 / 2934
页数：13
相关论文
共 50 条
  • [31] REAL-WORLD EFFECTIVENESS OF ERENUMAB IN CHRONIC MIGRAINE PROPHYLAXIS IN CROATIA: A PROSPECTIVE STUDY
    Bracic, Matea
    Lakusic, Darija Mahovic
    Jakus, Lukrecija
    CEPHALALGIA, 2020, 40 : 75 - 76
  • [32] REAL-WORLD CLINICAL CHARACTERISTICS OF PATIENTS WITH MIGRAINE WHO INITIATED FREMANEZUMAB IN SWEDEN: AN OBSERVATIONAL, NATIONWIDE REGISTERBASED STUDY
    Linde, M.
    Driessen, M.
    Akcicek, H.
    Blomstrand, F.
    Fast, T.
    Haas, J.
    Krasenbaum, L. J.
    Seidel, K.
    Vasilevska, M.
    Ernstsson, O.
    VALUE IN HEALTH, 2023, 26 (12) : S493 - S493
  • [33] Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysis
    Takizawa, Tsubasa
    Ohtani, Seiya
    Watanabe, Narumi
    Miyazaki, Naoki
    Ishizuchi, Kei
    Sekiguchi, Koji
    Iba, Chisato
    Shibata, Mamoru
    Takemura, Ryo
    Hori, Satoko
    Nakahara, Jin
    BMC NEUROLOGY, 2022, 22 (01)
  • [34] Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysis
    Tsubasa Takizawa
    Seiya Ohtani
    Narumi Watanabe
    Naoki Miyazaki
    Kei Ishizuchi
    Koji Sekiguchi
    Chisato Iba
    Mamoru Shibata
    Ryo Takemura
    Satoko Hori
    Jin Nakahara
    BMC Neurology, 22
  • [35] Real-world evidence of galcanezumab for migraine treatment in Japan: A retrospective analysis
    Takizawa, T.
    Ohtani, S.
    Watanabe, N.
    Miyazaki, N.
    Ishizuchi, K.
    Sekiguchi, K.
    Iba, C.
    Shibata, M.
    Takemura, R.
    Hori, S.
    Nakahara, J.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [36] Real-world evidence on fremanezumab for migraine treatment in Japan: a retrospective analysis
    Takizawa, T.
    Ohtani, S.
    Watanabe, N.
    Ihara, K.
    Takahashi, N.
    Miyazaki, N.
    Ishizuchi, K.
    Takemura, R.
    Hori, S.
    Nakahara, J.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [37] A real-world, observational study of erenumab for migraine prevention in Canadian patients with prior prophylactic treatment failure
    Becker, W. J.
    Spacey, S.
    Leroux, E. W.
    Giammarco, R.
    Lay, C.
    Gladstone, J.
    Christie, S.
    Power, G.
    Minhas, J. K.
    Mancini, J.
    Rochdi, D.
    Filiz, A.
    Bastien, N.
    HEADACHE, 2022, 62 : 131 - 132
  • [38] Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis
    Yuan, Hsiangkuo
    Natekar, Aniket
    Park, Jade
    Lauritsen, Clinton G.
    Viscusi, Eugene R.
    Marmura, Michael J.
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2023, 48 (12) : 581 - 587
  • [39] Erenumab Decreases Headache-Related Sick Leave Days and Health Care Visits: A Retrospective Real-World Study in Working Patients with Migraine
    Henri Autio
    Timo Purmonen
    Samu Kurki
    Emina Mocevic
    Minna A. Korolainen
    Samuli Tuominen
    Mariann I. Lassenius
    Markku Nissilä
    Neurology and Therapy, 2022, 11 : 223 - 235
  • [40] Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
    Done, Nicolae
    Bartolome, Lauren
    Swallow, Elyse
    Gao, Wei
    Carley, Christopher
    Wang, Travis
    Mostaghimi, Arash
    ACTA DERMATO-VENEREOLOGICA, 2023, 103
12345